Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Total Current Liabilities (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Total Current Liabilities data on record, last reported at $7.9 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 21.2% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $7.9 million, down 21.2%, while the annual FY2025 figure was $7.9 million, 21.2% down from the prior year.
  • Total Current Liabilities reached $7.9 million in Q4 2025 per PLSE's latest filing, down from $9.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $10.1 million in Q4 2024 and bottomed at $5.1 million in Q1 2024.
  • Average Total Current Liabilities over 5 years is $7.5 million, with a median of $7.3 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 152.08% in 2021, then decreased 27.32% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $6.7 million in 2021, then dropped by 10.84% to $6.0 million in 2022, then rose by 12.16% to $6.7 million in 2023, then soared by 49.9% to $10.1 million in 2024, then decreased by 21.2% to $7.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $7.9 million in Q4 2025, $9.7 million in Q3 2025, and $9.0 million in Q2 2025.